MXL MAXLINEAR, INC Insider Trading

Director Thomas E Pardun sold 11,000 MXL shares at $105.00 (52-week high near $106.28); stock down 8.0% from peak since sale.

Director Thomas E Pardun sold 11,000 (11.0K shares) of MAXLINEAR, INC (MXL) at $105.00 on 2026-05-26, reducing his holdings by 11,000 shares from 66,252 to 55,252 shares. The sale occurred near the 52-week high of $106.28, with current price at $97.76 representing an 8.0% decline from the peak. The company reported $137,188,000.00 revenue in the latest quarter but posted a net loss of $-45,137,000.00 and remains unprofitable on a full-year basis, despite annual revenue growth of +29.7%. This sale by a director during a period of operational losses and near a 52-week price peak merits investor attention to whether it signals reassessment of near-term valuation or reflects liquidity needs independent of fundamental conviction.

MaxLinear Corporate Controller Kwong Connie H. sells 35,000 shares worth ~$3.4M, cutting her holdings by roughly 80% near the 52-week high

Kwong Connie H., MaxLinear's Corporate Controller and Principal Accounting Officer, sold a combined 35,000 shares across two same-day transactions, reducing her stake by roughly eighty percent at prices near the stock's 52-week high — a level the stock had just reached after an extraordinary rally over the prior three months. The sheer scale of the reduction is notable: this is not a routine trim but a near-complete exit by a senior accounting officer who has direct visibility into the company's financial position. MaxLinear remains unprofitable despite strong revenue growth, which adds some context to the magnitude of this sale at elevated price levels. Looking back at Kwong's one prior open-market sale in this stock — her fourth open-market sale across all tickers in the 36-month window — the stock subsequently rose sharply in the weeks that followed, making that prior exit poorly timed. Whether history repeats itself here remains to be seen, but the track record from her single measurable prior sale at this ticker does not establish a pattern of well-timed exits.

Director Albert J. Moyer sells ~15,700 shares near 52-week highs amid explosive recent rally.

Albert J. Moyer, a MXL director, sold nearly 16,000 shares at the stock's current highs following a dramatic multi-month rally that saw the stock climb sharply from depressed levels. The timing is notable: the sale occurs at the peak of the recent surge, when the director reduced his holding by roughly a fifth. While the company faces significant profitability headwinds—posting substantial net losses despite strong revenue growth—the stock has nevertheless rallied aggressively, placing Moyer's sale squarely at a price peak. This pattern—a director exiting a sizable position after a sharp run-up in a fundamentally challenged company—suggests profit-taking rather than loss avoidance, though without visibility into Moyer's broader portfolio or tax situation, the motivation remains unclear. The filing merits attention as directional sentiment but should be weighed against the company's unprofitable financials and the volatile, rally-driven context of the sale.

MaxLinear C-suite insider sells ~$772K worth of shares (22% of holdings) amid stock recovery

A senior executive at MaxLinear sold approximately $772,000 worth of shares, representing roughly a fifth of their total holdings. The timing is noteworthy: the stock has recovered sharply from deeply depressed levels and is now trading notably below its recent highs, suggesting the insider may be taking profits after a substantial run-up. While the company's fundamentals show it is not currently profitable and is burning cash, it has demonstrated explosive revenue growth, indicating a business in turnaround or scaling phase. The sale size crosses the threshold for regulatory attention but doesn't represent a dramatic liquidation—the insider retained roughly 78% of their stake. Without knowledge of this executive's historical trading patterns or upcoming catalyst dates, this appears to be profit-taking by a disciplined insider, neither a panic dump nor evidence of fresh concerns about the business.

Steven G. Litchfield sells 102,157 shares at $17.28–$17.32 for $1.8M; holds 312.2K remaining as MXL trades -32.8% from 52-week high amid -48.0% revenue decline.

Steven G. Litchfield executed 2 separate sales totaling 102,157 shares for $1,765,118.58 on 2025-08-26, reducing his holdings by 24.7% to 312,203 shares. The transaction occurred while MaxLinear faces significant operational headwinds: the company reported a net loss of $26,586,000.00 on quarterly revenue of $108,813,000.00, and full-year revenue contracted -48.0% against the prior fiscal year. At the time of sale, MXL was trading at -32.8% from its 52-week high of $24.92, suggesting substantial investor repricing relative to broader valuation peaks. The insider's reduction of roughly one-quarter of his stake in a unprofitable company experiencing severe revenue contraction merits evaluation within the context of the company's financial deterioration and the stock's broader retreat from recent highs.

CEO Kishore bought 108,303 shares of MXL at $12.94 on 2024-07-30 after 56.4% stock decline from 52-week high.

SEENDRIPU KISHORE, as Chairman, President and CEO, purchased 108,303 shares for $1,401,592.44, increasing his holdings by 25.6% to 531,937 shares. The purchase occurred at $12.94, which is currently $12.90 (flat) but represents a 56.4% discount from the 52-week high of $29.61 and follows a 36.0% 30-day decline. This buy by the company's top executive during a period of significant stock depreciation and material business deterioration—revenue contracted 38.1% year-over-year, the company reported a $-39.3M net loss in the latest quarter, and full-year net income was negative—suggests the CEO is willing to commit substantial personal capital at depressed valuations. The magnitude of the position increase (108.3K shares, +25.6%) and the timing relative to the stock's technical weakness warrant investor scrutiny of the underlying drivers of the recent stock decline and the CEO's conviction regarding the company's recovery path.